Risk assessment and surveillance for bovine spongiform encephalopathy

被引:13
|
作者
Heim, D.
Gardner, I.
Mumford, E.
Kihm, U.
机构
[1] Swiss Fed Vet Off, CH-3003 Bern, Switzerland
[2] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA
[3] Safe Food Solut Inc, CH-3012 Bern, Switzerland
关键词
bovine spongiform encephalopathy; cattle; risk assessment; surveillance; transmissible spongiform encephalopathy;
D O I
10.20506/rst.25.3.1705
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The national risk of bovine spongiform encephalopathy (BSE) has not been assessed by many countries, and many countries are conducting little or no BSE surveillance. National measures implemented, including import restrictions, surveillance systems, and sanitary controls, should be based on actual BSE risk. Thus, as a first step, the national BSE status must be determined, particularly through assessment of the national risk. The World Organisation for Animal Health (OIE) provides recommendations for surveillance and risk assessment of BSE, which are considered the international standard by the World Trade Organization (WTO). This document describes the variables for determination of BSE status and gives guidance on specific options and practical considerations for meeting the BSE surveillance and risk assessment recommendations of the OIE.
引用
收藏
页码:937 / 950
页数:14
相关论文
共 50 条
  • [1] Risk assessment and surveillance for bovine spongiform encephalopathy (BSE) in Argentina
    Schudel, AA
    Carrillo, BJ
    Weber, EL
    Viera, JB
    Gimeno, EJ
    vanGelderen, C
    Ulloa, E
    Nader, A
    Cane, BG
    Kimberlin, RH
    [J]. PREVENTIVE VETERINARY MEDICINE, 1996, 25 (3-4) : 271 - 284
  • [2] BOVINE SPONGIFORM ENCEPHALOPATHY SURVEILLANCE IN ARGENTINA
    SCHUDEL, AA
    CARRILLO, BJ
    GIMENO, EJ
    WEBER, EL
    VIERA, JB
    VANGELDEREN, C
    ULLOA, E
    NADER, A
    CANE, BG
    [J]. REVUE SCIENTIFIQUE ET TECHNIQUE DE L OFFICE INTERNATIONAL DES EPIZOOTIES, 1994, 13 (03): : 801 - 818
  • [3] A Quantitative Risk Assessment for Bovine Spongiform Encephalopathy in Japan
    Kadohira, M.
    Stevenson, M. A.
    Hogasen, H. R.
    de Koeijer, A.
    [J]. RISK ANALYSIS, 2012, 32 (12) : 2198 - 2208
  • [4] Assessment of the risk factors related to bovine spongiform encephalopathy
    Morley, RS
    Chen, S
    Rheault, N
    [J]. REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES, 2003, 22 (01): : 157 - 178
  • [5] Bovine spongiform encephalopathy surveillance in the Republic of Korea
    Lee, Y. H.
    Kim, M. J.
    Tark, D. S.
    Sohn, H. J.
    Yun, E. I.
    Cho, I. S.
    Choi, Y. P.
    Kim, C. L.
    Lee, J. H.
    Kweon, C. H.
    Joo, Y. S.
    Chung, G. S.
    Lee, J. H.
    [J]. REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES, 2012, 31 (03): : 861 - 870
  • [6] BOVINE SPONGIFORM ENCEPHALOPATHY AND RISK TO HEALTH
    COYLE, E
    HARVEY, I
    [J]. BRITISH MEDICAL JOURNAL, 1992, 304 (6840): : 1509 - 1509
  • [7] RISK-FACTORS AND SURVEILLANCE FOR BOVINE SPONGIFORM ENCEPHALOPATHY IN THE UNITED-STATES
    BLEEM, AM
    CROM, RL
    FRANCY, DB
    HUESTON, WD
    KOPRAL, C
    WALKER, K
    [J]. JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1994, 204 (04) : 644 - 651
  • [8] BOVINE SPONGIFORM ENCEPHALOPATHY AND RISK TO HEALTH
    WILL, RG
    IRONSIDE, JW
    BELL, JE
    [J]. BRITISH MEDICAL JOURNAL, 1992, 305 (6844): : 53 - 53
  • [9] Assessment of risk of bovine spongiform encephalopathy in pharmaceutical products, Part 1
    Bader, F
    Davis, G
    Dinowitz, M
    Garfinkle, B
    Harvey, J
    Kozak, R
    Lubiniecki, A
    Rubino, M
    Schubert, D
    Wiebe, M
    Woollett, G
    [J]. BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, 1998, 11 (01): : 20 - +
  • [10] Bovine spongiform encephalopathy: the surveillance between past and future
    Desiato, R.
    Maurella, C.
    Iulini, B.
    Pautasso, A.
    Colussi, S.
    Meloni, D.
    Ru, G.
    Casalone, C.
    Caramelli, M.
    [J]. LARGE ANIMAL REVIEW, 2014, 20 (03): : 99 - 102